BioCryst Pharmaceuticals, Inc.
BCRXUpdated . Prices are snapshots and may be delayed.
BioCryst Pharmaceuticals, Inc. price chart
AI Outlook for BioCryst Pharmaceuticals, Inc.
Bearish posture- Long-term trend-10.6% vs 200-day average
- Medium-term trend-13.5% vs 50-day average
- Averages50-day above 200-day
- 3 more trend and momentum checks
- Nearby support and resistance levels
- What would strengthen or weaken the picture
Posture describes where the price stands today, from its own trend and momentum. It is not a forecast, a price target or financial advice. How it is worked out
BioCryst Pharmaceuticals, Inc. performance
About BioCryst Pharmaceuticals, Inc.
BioCryst Pharmaceuticals, Inc. is a biotechnology company based in the United States, listed on NASDAQ since 1994 (ticker BCRX).
The shares trade at a price-to-earnings ratio of 8.0.
BioCryst Pharmaceuticals, Inc. market data
What is the price of BioCryst Pharmaceuticals, Inc. today?
BioCryst Pharmaceuticals, Inc. (BCRX) is at $7.79, −2.14% on the day.
What is the 52-week range of BioCryst Pharmaceuticals, Inc.?
Over the past year BioCryst Pharmaceuticals, Inc. has traded between $6.00 and $11.22. It is currently 34% of the way up that range.
What is the P/E ratio of BioCryst Pharmaceuticals, Inc.?
BioCryst Pharmaceuticals, Inc. trades at a price-to-earnings ratio of 8.0.
Similar stocks
Prices are snapshots from market data providers and may be delayed. This page is for information only and is not investment advice.